Transgenic rice, Oryza sativa L., cells were cultured to produce human cytotoxic T-lymphocyte antigen 4-immunoglobulin (hCTLA4Ig), a fusion protein used for the treatment of rheumatoid arthritis. This plant cell culture system with the signal peptide for the secretion of target protein into the extracellular medium and the inducible RAmy3D promoter was used for the production of the recombinant therapeutic protein in order to overcome the constraint of low production level.1) However, the RAmy3D promoter system has a drawback in decreasing cell viability because the promoter is induced only by sugar starvation. The cell death stimulated the release of protease, which degraded target protein.2) In order to solve these instability problems of the product after secretion, in situ product recovery was performed by using a modified flask.3) The modified flask was specially designed with glass filter to make medium exchange easy and successful. The medium exchange provided an improved culture condition for the cells because proteases could be removed from the culture environment by dilution with new medium after exchange. Contrary to the expectation, it was found that the production level of hCTLA4Ig was not increased despite of the better maintenance of cell mass than those of control. These results show that in situ product recovery using a modified flask could not enhance the production of hCTLA4Ig in transgenic rice cell culture system.
한국생물공학회 [The Korean Society for Biotechnology and Bioengineering]
설립연도
1984
분야
공학>생물공학
소개
이 법인은 생물 공학의 발전과 보급에 이바지하고, 회원 상호 간의 연구 협력과 친목을 도모함을 목적으로 한다
1. 생물공학 분야의 발전을 위한 연구 협력
2. 생물공학의 실용화를 촉진시키기 위한 산학 협동
3. 학술연구 발표회, 강연회, 연수회 등 학술활동의 개최
4. 국,영문 학술지,소식지,학술회의 Proceedings 및 학술도서의 발간
5. 생물공학 발전을 위한 정책 건의
6. 기타 국제 교류 등 본 학회의 목적 달성을 위한 제반 활동